ARCHIVES

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | March 27, 1998

Download PDF Visit The Full Archive

Related Articles

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

Combination Radiation/Vaccine May Benefit Some Patients

April 29, 2005

Gene Expression Analyses Can Guide MDS Treatments

December 30, 2011

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013